Relay Technology Management Announces Pipeline-by-Pathway Target Searching to Enable Biologically-Based Business Intelligence for the Pharmaceutical Industry
Launch of Version 1.2 of Business Development Live (BD Live!) Establishes Diverse and Thorough Drug-Target Relationships, Enables Competitive Intelligence at the Molecular Level
(firmenpresse) - CAMBRIDGE, MA -- (Marketwire) -- 12/18/12 -- Relay Technology Management Inc. is pleased to announce the release of the pipeline-by-pathway target searching module as part of version 1.2 of , Relay's flagship real-time comparative asset analysis and trend analytics software-as-a-service for the life sciences industry. From protein sequences to inhibitor connections, BD Live! enables life sciences professionals to access the largest real-time database of company-target-drug relationships and access rich data on industry trends.
"We wanted to provide our customers with a tool that enabled them to look at competitive intelligence at the molecular level," says Dr. David Greenwald, Managing Director and Co-Founder of Relay. "Now, users of BD Live! have the capability to search by molecular target of interest in order to identify the competitive landscape, not only at the pipeline level but within patents and publications. All associations are backed up by existing aspects of BD Live!, including source document transparency and live daily updates."
Relay's BD Live! system is built upon an ontologically-driven text mining approach that leverages real time data from an ever-expanding set of sources to establish data-driven, transparent relationships within scientific, clinical, and industry data. The pipeline-by-pathway target searching module enables business professionals in life science and biopharmaceutical firms to interact with competitive intelligence data and transactional information on a biologic basis. The user can move seamlessly from therapeutic hypothesis through to asset identification and benchmarking in one simple process.
The software platform which powers BD Live!, The Relay Innovation Engine, indexes over 100 million documents, and categorizes over 38,000 drugs, 16,000 companies, and 37,000 drug targets and genes. In addition to its standard set of data visualizations and analytics offered to all users, Relay's suite of customizable dashboards enables us to deploy solutions that are highly customized to each client's needs. The pipeline-by-pathway module has established over 5,000 unique data driven drug-target relationships within clinical and approved drugs.
Relay Technology Management () is a life sciences business intelligence and asset comparison software provider. The company's Relay Innovation Engine software platform powers BD Live! to support business development and corporate strategy professionals in the life science industry confirm the attractiveness of assets under consideration and unearth new technologies. Relay aims to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics.
Follow Relay Technology Management on the , , , and .
Allyson Galle
Relay Technology Management, Inc.
Email:
Phone: 877-207-3529
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 18.12.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 1181296
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
CAMBRIDGE, MA
Phone:
Kategorie:
Peripherals
Anmerkungen:
Diese Pressemitteilung wurde bisher 142 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Relay Technology Management Announces Pipeline-by-Pathway Target Searching to Enable Biologically-Based Business Intelligence for the Pharmaceutical Industry
"
steht unter der journalistisch-redaktionellen Verantwortung von
Relay Technology Management (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
